Cure My Disease

Don't miss your cure!

 Log in / Sign up

New NanoKnife treatment shows promise for prostate cancer

NCT ID NCT04972097

Completed Disease control Sponsor: Angiodynamics, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a device called NanoKnife to treat prostate cancer in 121 men with intermediate-risk disease. The goal was to safely destroy cancer tissue while avoiding major side effects. Researchers checked if the treated area was cancer-free after 12 months and tracked any device-related problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTERMEDIATE RISK PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer prostate carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

  • Duke University

    Durham, North Carolina, 27710, United States

  • Duly Health and Care

    Lisle, Illinois, 60532, United States

  • Fox Chase Cancer Center

    Philadelphia, Pennsylvania, 19111, United States

  • Mayo Clinic

    Rochester, Minnesota, 55905, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 10065, United States

  • Moffitt Cancer Center

    Tampa, Florida, 33612, United States

  • NYU Langone Health

    New York, New York, 10017, United States

  • Northshore University Healthsystem

    Evanston, Illinois, 60201, United States

  • Northwell Health

    New York, New York, 10022, United States

  • Rush University Medical Center

    Chicago, Illinois, 60612, United States

  • University of California Irvine

    Orange, California, 92868, United States

  • University of Cincinnati

    Cincinnati, Ohio, 45221, United States

  • University of Colorado

    Aurora, Colorado, 80045, United States

  • University of Florida Health

    Gainesville, Florida, 32610, United States

  • University of Texas Southwestern Medical Center

    Dallas, Texas, 75390, United States

  • VA Ann Arbor Health Care

    Ann Arbor, Michigan, 48105, United States

  • Weill Cornell Medicine

    New York, New York, 10065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.